Clinical Trials Directory

Trials / Completed

CompletedNCT01849926

Ibuprofen Versus Mecillinam for Uncomplicated Cystitis

Ibuprofen Versus Mecillinam for Uncomplicated Cystitis in Adult, Non-pregnant Women

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
383 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Although uncomplicated cystitis is considered to be a mild condition and mostly self limiting, most patients who see a doctor will be treated with antibiotics. Antibiotics are known to give a quick relief of symptoms and shorten the course of the condition by a few days. The aim of this study is to evaluate ibuprofen versus mecillinam in the treatment of uncomplicated cystitis in otherwise healthy, non-pregnant women. Our main objective is to see whether symptomatic treatment with ibuprofen is equally efficient as treatment with mecillinam in this group.

Detailed description

The design of the study will be a double blinded randomized controlled trial (RCT). Half of the patients will receive treatment with mecillinam and the other half will receive treatment with ibuprofen. The study will follow the principles of Good Clinical Practice (GCP). Urine cultures will be obtained on day one and after two weeks. The patients will be given a diary where they daily will register symptom load, possible complications or adverse effects and on which day they feel completely cured. We will contact the patients after two weeks to make sure they have followed the study procedures. After four weeks we will perform a final interview with the patient.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen
DRUGMecillinam

Timeline

Start date
2013-04-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2013-05-09
Last updated
2017-11-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01849926. Inclusion in this directory is not an endorsement.